GSA CAPITAL PARTNERS LLP - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2023$87
+8.8%
12,024
+4.0%
0.01%
-12.5%
Q1 2023$80
-68.0%
11,561
-52.5%
0.01%
-74.2%
Q4 2022$250
-99.9%
24,319
+3.6%
0.03%
-45.6%
Q3 2022$427,000
+7.3%
23,467
+334.3%
0.06%
+7.5%
Q1 2022$398,000
+25.2%
5,404
+143.0%
0.05%
+32.5%
Q4 2021$318,000
+61.4%
2,224
-93.4%
0.04%
+81.8%
Q2 2019$197,00033,5520.02%
Other shareholders
NOVAVAX INC shareholders Q1 2022
NameSharesValueWeighting ↓
RA Capital Management 2,559,918$543,496,0008.72%
Foresite Capital Management I, LLC 66,810$14,184,0008.55%
Samsara BioCapital, LLC 198,600$42,165,0005.20%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 330,541$70,177,0004.54%
Foresite Capital Management II, LLC 67,373$14,304,0003.85%
Rock Springs Capital Management LP 455,000$96,601,0001.91%
DELTEC ASSET MANAGEMENT LLC 56,320$11,957,0001.65%
Parametrica Management Ltd 10,200$2,166,0001.60%
SECTORAL ASSET MANAGEMENT INC 88,450$18,779,0001.52%
TSP Capital Management Group, LLC 18,525$3,933,0001.29%
View complete list of NOVAVAX INC shareholders